These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16652345)

  • 1. Neuroblastomas that might benefit from mass screening at 6 months of age in Japan.
    Kaneko Y
    Pediatr Blood Cancer; 2007 Feb; 48(2):245-6; author reply 247. PubMed ID: 16652345
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the mass screening for neuroblastoma ineffective?
    Nishi M; Hanai J; Fujita K; Ichimiya H; Tanaka T; Hatae Y; Takeda T
    J Exp Clin Cancer Res; 2003 Dec; 22(4):673-6. PubMed ID: 15053313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroblastoma screening in early life.
    Suita S
    N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12226161
    [No Abstract]   [Full Text] [Related]  

  • 4. Congenital cardiovascular malformations are complicated in neuroblastomas identified by mass screening but not by clinical examination in Japan.
    Yanai T; Hasegawa D; Kosaka Y; Misu H; Mabuchi O; Ogino W; Hayakawa A; Kawasaki K; Takeshima Y; Matsuo M
    J Pediatr; 2006 Jul; 149(1):145-6; author reply 146. PubMed ID: 16860148
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group.
    Sawada T; Shikata T; Matsumura T; Kawakatsu H; Sugimoto T
    Prog Clin Biol Res; 1994; 385():371-5. PubMed ID: 7972233
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuroblastoma and mass examination].
    Sawada T; Tanaka T
    Kango Gijutsu; 1985 Jun; 31(8):1109-11. PubMed ID: 3848548
    [No Abstract]   [Full Text] [Related]  

  • 7. Mass screening for neuroblastoma in Japan. Committee of the Neuroblastoma Mass Screening Study of the Japanese Society of Pediatric Oncology.
    Sawada T; Nagahara N; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Okawa H; Tsunoda A; Sakurai M
    Acta Paediatr Jpn; 1990 Dec; 32(6):725-33. PubMed ID: 2082676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass screening for neuroblastoma in infancy. The Japanese Mass Screening Study Group of Neuroblastoma.
    Sawada T; Sugimoto T; Matsumura T; Tunoda A; Takeda T; Yamamoto K; Koide R; Nagahara N; Hanawa Y; Nishihira K
    Prog Clin Biol Res; 1988; 271():525-34. PubMed ID: 3406016
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuroblastoma screening in early life.
    Collins MH
    N Engl J Med; 2002 Sep; 347(11):852-4; author reply 852-4. PubMed ID: 12227370
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for neuroblastoma.
    Weinblatt M
    Pediatrics; 1988 Jan; 81(1):175-7. PubMed ID: 3336591
    [No Abstract]   [Full Text] [Related]  

  • 11. A halt to neuroblastoma screening in Japan.
    Tsubono Y; Hisamichi S
    N Engl J Med; 2004 May; 350(19):2010-1. PubMed ID: 15128908
    [No Abstract]   [Full Text] [Related]  

  • 12. Trend in the number of registrations for neuroblastoma in Japan.
    Kawada T
    Jpn J Clin Oncol; 2012 Apr; 42(4):357-8. PubMed ID: 22345704
    [No Abstract]   [Full Text] [Related]  

  • 13. Report of the 1998 Consensus Conference on Neuroblastoma Screening.
    Med Pediatr Oncol; 1999 Oct; 33(4):357-9. PubMed ID: 10491542
    [No Abstract]   [Full Text] [Related]  

  • 14. Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan.
    Yamamoto K; Ohta S; Ito E; Hayashi Y; Asami T; Mabuchi O; Higashigawa M; Tanimura M
    J Clin Oncol; 2002 Mar; 20(5):1209-14. PubMed ID: 11870162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma screening in Japan: population-based cohort study and future aspects of screening.
    Hiyama E
    Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):88-4. PubMed ID: 19904462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of neuroblastoma in Sapporo city.
    Nishi M; Miyake H; Takeda T; Shimada M; Takasugi N; Sato Y; Hanai J
    J Pediatr Surg; 1990 May; 25(5):545-6. PubMed ID: 2191108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a future for neuroblastoma mass screening?
    Bessho F
    Med Pediatr Oncol; 1998 Aug; 31(2):106-10. PubMed ID: 9680937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass screening for neuroblastoma at 6 months of age: difficult to justify.
    Suita S; Tajiri T; Akazawa K; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Tasaka H; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1998 Nov; 33(11):1674-8. PubMed ID: 9856893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of 25 neuroblastomas revealed by mass screening in Japan.
    Sawada T
    Lancet; 1986 Feb; 1(8477):377. PubMed ID: 2868308
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of unfavorable character among neuroblastomas detected through mass screening. The Japanese Infantile Neuroblastoma Cooperative Study.
    Tanaka T; Matsumura T; Iehara T; Sawada T
    Med Pediatr Oncol; 2000 Dec; 35(6):705-7. PubMed ID: 11107151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.